UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression

The New England journal of medicine, 2017-06, Vol.376 (26), p.2523-2533

2017

Volltextzugriff (PDF)

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder

British journal of psychiatry, 2007-04, Vol.190 (4), p.359-360

2007

Volltextzugriff (PDF)

Antidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical Trial

PloS one, 2016-05, Vol.11 (5), p.e0154195-e0154195

2016

Volltextzugriff (PDF)

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

The world journal of biological psychiatry, 2013-02, Vol.14 (1), p.2-44

2013

Volltextzugriff (PDF)

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation

The world journal of biological psychiatry, 2015-04, Vol.16 (3), p.142-170

2015

Volltextzugriff (PDF)

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

The world journal of biological psychiatry, 2012-07, Vol.13 (5), p.318-378

2012

Volltextzugriff (PDF)

Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression

Progress in neuro-psychopharmacology & biological psychiatry, 2018-08, Vol.86, p.211-217

2018

Volltextzugriff (PDF)

Diagnosis and biomarkers of predementia in Alzheimer's disease

BMC medicine, 2010-12, Vol.8 (1), p.89-89, Article 89

2010

Volltextzugriff (PDF)

Reduced Annexin A3 in schizophrenia

European archives of psychiatry and clinical neuroscience, 2020-06, Vol.270 (4), p.489-494

2020

Volltextzugriff (PDF)

Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease

Neuromolecular medicine, 2013-03, Vol.15 (1), p.115-121

2013

Volltextzugriff (PDF)

Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study

European archives of psychiatry and clinical neuroscience, 2020-06, Vol.270 (4), p.483-488

2020

Volltextzugriff (PDF)

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

Schizophrenia research, 2008-03, Vol.100 (1), p.20-38

2008

Volltextzugriff (PDF)

Stereologic investigation of the posterior part of the hippocampus in schizophrenia

Acta neuropathologica, 2009-04, Vol.117 (4), p.395-407

2009

Volltextzugriff (PDF)

Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia

European archives of psychiatry and clinical neuroscience, 2009-04, Vol.259 (3), p.151-163

2009

Volltextzugriff (PDF)

Increased PLA2 activity in individuals at ultra-high risk for psychosis

European archives of psychiatry and clinical neuroscience, 2021-12, Vol.271 (8), p.1593-1599

2021

Volltextzugriff (PDF)

Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation

BMC psychiatry, 2009-04, Vol.9 (17), p.17-17, Article 17

2009

Volltextzugriff (PDF)

Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic Concentrations

Current Alzheimer research, 2016-08, Vol.13 (8), p.848-852

2016

Volltextzugriff (PDF)

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme

Psychopharmacologia, 2008-05, Vol.198 (1), p.1-27

2008

Volltextzugriff (PDF)

Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis

JAMA psychiatry (Chicago, Ill.), 2017-02, Vol.74 (2), p.143

2017

Volltextzugriff (PDF)

Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia

Journal of psychiatric research, 2009-07, Vol.43 (11), p.978-986

2009

Volltextzugriff (PDF)

Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis

Journal of Neural Transmission, 2009-03, Vol.116 (3), p.275-289

2009

Volltextzugriff (PDF)

Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness

NeuroImage clinical, 2016-01, Vol.12 (C), p.1-15

2016

Volltextzugriff (PDF)

Antipsychotics preserve telomere length in peripheral blood mononuclear cells after acute oxidative stress injury

Neural regeneration research, 2022-05, Vol.17 (5), p.1156-1160

2022

Volltextzugriff (PDF)

Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study

Neuroscience letters, 2011-04, Vol.494 (1), p.54-56

2011

Volltextzugriff (PDF)

Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression

The American journal of geriatric psychiatry, 2013-05, Vol.21 (5), p.493-496

2013

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(312)
Mit Volltextzugriff
(281)

Publikationsform

Sprache

Englisch
(318)
Japanisch
(42)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(190)
Life Sciences & Biomedicine
(188)
Humans
(173)
Psychiatry
(166)
Male
(135)
Female
(126)
Adult
(110)
Neurosciences & Neurology
(91)
Biological And Medical Sciences
(80)
Medical Sciences
(74)
Psychology. Psychoanalysis. Psychiatry
(72)
Neurosciences
(71)
Schizophrenia
(67)
Middle Aged
(64)
Clinical Neurology
(58)
Psychopathology. Psychiatry
(57)
Adult And Adolescent Clinical Studies
(50)
Aged
(46)
Bipolar Disorder
(42)
Neurology
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder

Antidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical Trial

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression

Diagnosis and biomarkers of predementia in Alzheimer's disease

Reduced Annexin A3 in schizophrenia

Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease

Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

Stereologic investigation of the posterior part of the hippocampus in schizophrenia

Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia

Increased PLA2 activity in individuals at ultra-high risk for psychosis

Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation

Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic Concentrations

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme

Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis

Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia

Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis

Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness

Antipsychotics preserve telomere length in peripheral blood mononuclear cells after acute oxidative stress injury

Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study

Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression

Aktive Filter

Suchergebnisse filtern